Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the Addition of DEBRICHEM® to the Routine Management of Chronic Diabetic Foot Wounds: an Open-label Randomized Controlled Trial (CHEMfoot Study)

NCT07206862 is registered in ClinicalTrials.gov with DEBx Medical B.V. as lead sponsor.

NCT NCT07206862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07206862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the Addition of DEBRICHEM® to the Routine Management of Chronic Diabetic Foot Wounds: an Open-label Randomized Controlled Trial (CHEMfoot Study)
Lead sponsor
DEBx Medical B.V.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
February 28, 2027
Enrollment
242 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer (dfu), diabetic foot ulcer treatment, diabetic foot wounds